Shares of Viatris Inc. VTRS slipped 1.03% to $10.62 Monday, on what proved to be an all-around positive trading session for ...
CVS' Aetna sues drug manufacturers for price-fixing and market allocation scheme. The subsidiary seeks damages and injunctions. Vandana Singh Big Biopharma Trails Behind The Market: JP Morgan's ...
7d
Barchart on MSNViatris Stock Outlook: Is Wall Street Bullish or Bearish?Viatris Inc. (VTRS) is a global healthcare company formed through the merger of Mylan and Upjohn (a division of Pfizer) in ...
Check the time stamp on this data. Updated AI-Generated Signals for Viatris Inc. (VTRS) available here: VTRS. Type a few ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
VTRS is currently sporting a Zacks Rank of #2 (Buy), as well as a Value grade of A. Value investors also love the P/S ratio, which is calculated by simply dividing a stock's price with the company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results